Return On Equity of X4 Pharmaceuticals, Inc from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
X4 Pharmaceuticals, Inc quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • X4 Pharmaceuticals, Inc Return On Equity for the quarter ending 30 Sep 2025 was -344%, a 957% decline year-over-year.
  • X4 Pharmaceuticals, Inc annual Return On Equity for 2024 was -85%, a 50% increase from 2023.
  • X4 Pharmaceuticals, Inc annual Return On Equity for 2023 was -170%, a 2.3% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Return On Equity for 2022 was -174%, a 60% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

X4 Pharmaceuticals, Inc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -344% -311% -957% 01 Jul 2025 30 Sep 2025
Q2 2025 -375% -408% -1240% 01 Apr 2025 30 Jun 2025
Q1 2025 29% +305% 01 Jan 2025 31 Mar 2025
Q4 2024 -85% +86% +50% 01 Oct 2024 31 Dec 2024
Q3 2024 -33% +138% +81% 01 Jul 2024 30 Sep 2024
Q2 2024 33% +237% 01 Apr 2024 30 Jun 2024
Q1 2024 -275% -99% -56% 01 Jan 2024 31 Mar 2024
Q4 2023 -170% +4% +2.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -170% +14% +7.6% 01 Jul 2023 30 Sep 2023
Q2 2023 -204% -29% -16% 01 Apr 2023 30 Jun 2023
Q1 2023 -176% -40% -29% 01 Jan 2023 31 Mar 2023
Q4 2022 -174% -65% -60% 01 Oct 2022 31 Dec 2022
Q3 2022 -184% -92% -100% 01 Jul 2022 30 Sep 2022
Q2 2022 -176% -92% -110% 01 Apr 2022 30 Jun 2022
Q1 2022 -136% -61% -82% 01 Jan 2022 31 Mar 2022
Q4 2021 -109% -45% -69% 01 Oct 2021 31 Dec 2021
Q3 2021 -92% -43% -87% 01 Jul 2021 30 Sep 2021
Q2 2021 -84% -33% -65% 01 Apr 2021 30 Jun 2021
Q1 2021 -75% -25% -49% 01 Jan 2021 31 Mar 2021
Q4 2020 -64% -1% -1.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -49% +112% +69% 01 Jul 2020 30 Sep 2020
Q2 2020 -51% -1012% -105% 01 Apr 2020 30 Jun 2020
Q1 2020 -50% -132% -162% 01 Jan 2020 31 Mar 2020
Q4 2019 -63% -113% -227% 01 Oct 2019 31 Dec 2019
Q3 2019 -161% -221% -367% 01 Jul 2019 30 Sep 2019
Q2 2019 961% 01 Apr 2019 30 Jun 2019
Q1 2019 81% 01 Jan 2019 31 Mar 2019
Q4 2018 50% 01 Oct 2018 31 Dec 2018
Q3 2018 60% 01 Jul 2018 30 Sep 2018

X4 Pharmaceuticals, Inc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -85% +86% +50% 01 Jan 2024 31 Dec 2024
2023 -170% +4% +2.3% 01 Jan 2023 31 Dec 2023
2022 -174% -65% -60% 01 Jan 2022 31 Dec 2022
2021 -109% -45% -69% 01 Jan 2021 31 Dec 2021
2020 -64% -1% -1.7% 01 Jan 2020 31 Dec 2020
2019 -63% -116% -220% 01 Jan 2019 31 Dec 2019
2018 53% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.